EMD
Click for more information
5.00% 3.8¢ emyria limited

Ann: Phase 1 trial commences Q1, 2022 for Emyrias ultra-pure CBD, page-2

  1. Sweapon
    1,731 Posts.
    lightbulb Created with Sketch. 168
    clock Created with Sketch.
    20/01/22
    09:57
    Post #: 58998347
    I found this part really interesting, "recently completed animal studies evaluating EMD-RX5 suggest that it has improved bioavailability compared to Epidyolex". Basically you can ingest less and still have the same or greater CBD therapeutic benefit, pretty exciting stuff.

    EMD Price at posting: 44.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 13  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS The psychology of spending: How to manage finances wisely
right-arrow Created with Sketch.
NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS HotCopper users bullish on Raiden's news it won Andover South approval as expected
right-arrow Created with Sketch.
NEWS Outstanding metallurgical results significantly de-risk Mandilla gold project
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
watchlist Created with Sketch. Add EMD (ASX) to my watchlist
(20min delay)
Last
3.8¢ 		Change
-0.002(5.00%) 		Mkt cap ! $15.54M
Open High Low Value Volume
3.8¢ 3.8¢ 3.8¢ $227 5.973K

Buyers (Bids)

No. Vol. Price($)
2 7337 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 120999 1
View Market Depth
Last trade - 15.06pm 18/09/2024 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.